453 related articles for article (PubMed ID: 28404755)
1. NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Lyons J; Marcom PK; Mayer IA; McCormick B; Moran MS; O'Regan RM; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Sitapati A; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
J Natl Compr Canc Netw; 2017 Apr; 15(4):433-451. PubMed ID: 28404755
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management of the axilla in breast cancer.
Nurudeen S; Hunt KK
Clin Adv Hematol Oncol; 2018 Dec; 16(12):823-831. PubMed ID: 30843891
[TBL] [Abstract][Full Text] [Related]
3. NCCN Guidelines Insights Breast Cancer, Version 1.2016.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz M; Goldstein LJ; Hudis CA; Isakoff SJ; Marcom PK; Mayer IA; McCormick B; Moran M; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
J Natl Compr Canc Netw; 2015 Dec; 13(12):1475-85. PubMed ID: 26656517
[TBL] [Abstract][Full Text] [Related]
4. NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
Goetz MP; Gradishar WJ; Anderson BO; Abraham J; Aft R; Allison KH; Blair SL; Burstein HJ; Dang C; Elias AD; Farrar WB; Giordano SH; Goldstein LJ; Isakoff SJ; Lyons J; Marcom PK; Mayer IA; Moran MS; Mortimer J; O'Regan RM; Patel SA; Pierce LJ; Reed EC; Rugo HS; Sitapati A; Smith KL; Smith ML; Soliman H; Telli ML; Ward JH; Young JS; Shead DA; Kumar R
J Natl Compr Canc Netw; 2019 Feb; 17(2):118-126. PubMed ID: 30787125
[TBL] [Abstract][Full Text] [Related]
5. NCCN Guidelines Updates: Breast Cancer.
Telli ML; Gradishar WJ; Ward JH
J Natl Compr Canc Netw; 2019 May; 17(5.5):552-555. PubMed ID: 31117035
[TBL] [Abstract][Full Text] [Related]
6. Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice.
Gera R; Kasem A; Mokbel K
In Vivo; 2018; 32(6):1301-1307. PubMed ID: 30348682
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Version 2.2015.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz M; Goldstein LJ; Hudis CA; Isakoff SJ; Marcom PK; Mayer IA; McCormick B; Moran M; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
J Natl Compr Canc Netw; 2015 Apr; 13(4):448-75. PubMed ID: 25870381
[TBL] [Abstract][Full Text] [Related]
8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
9. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.
Hartmann S; Reimer T; Gerber B; Stubert J; Stengel B; Stachs A
Eur J Surg Oncol; 2018 Sep; 44(9):1307-1311. PubMed ID: 29935839
[TBL] [Abstract][Full Text] [Related]
10. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
Gradishar WJ; Moran MS; Abraham J; Aft R; Agnese D; Allison KH; Blair SL; Burstein HJ; Dang C; Elias AD; Giordano SH; Goetz MP; Goldstein LJ; Hurvitz SA; Isakoff SJ; Jankowitz RC; Javid SH; Krishnamurthy J; Leitch M; Lyons J; Matro J; Mayer IA; Mortimer J; O'Regan RM; Patel SA; Pierce LJ; Rugo HS; Sitapati A; Smith KL; Smith ML; Soliman H; Stringer-Reasor EM; Telli ML; Ward JH; Wisinski KB; Young JS; Burns JL; Kumar R
J Natl Compr Canc Netw; 2021 May; 19(5):484-493. PubMed ID: 34794122
[TBL] [Abstract][Full Text] [Related]
11. Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz M; Goldstein LJ; Hudis CA; Isakoff SJ; Marcom PK; Mayer IA; McCormick B; Moran M; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
J Natl Compr Canc Netw; 2016 Mar; 14(3):324-54. PubMed ID: 26957618
[TBL] [Abstract][Full Text] [Related]
12. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer, version 3.2013: featured updates to the NCCN guidelines.
Theriault RL; Carlson RW; Allred C; Anderson BO; Burstein HJ; Edge SB; Farrar WB; Forero A; Giordano SH; Goldstein LJ; Gradishar WJ; Hayes DF; Hudis CA; Isakoff SJ; Ljung BM; Mankoff DA; Marcom PK; Mayer IA; McCormick B; Pierce LJ; Reed EC; Schwartzberg LS; Smith ML; Soliman H; Somlo G; Ward JH; Wolff AC; Zellars R; Shead DA; Kumar R;
J Natl Compr Canc Netw; 2013 Jul; 11(7):753-60; quiz 761. PubMed ID: 23847214
[TBL] [Abstract][Full Text] [Related]
14. The Evolution of Axillary Staging in Breast Cancer.
Rao R
Mo Med; 2015; 112(5):385-8. PubMed ID: 26606821
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in early breast cancer. A review on recent and ongoing randomized trials.
Esposito E; Di Micco R; Gentilini OD
Breast; 2017 Dec; 36():14-19. PubMed ID: 28854395
[TBL] [Abstract][Full Text] [Related]
16. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
Poodt IGM; Rots ML; Vugts G; van Dalen T; Kuijer A; Vriens BEPJ; Nieuwenhuijzen GAP; Schipper RJ
Eur J Surg Oncol; 2018 Aug; 44(8):1151-1156. PubMed ID: 29580733
[TBL] [Abstract][Full Text] [Related]
17. Prediction of non-SN involvement in patients with SN isolated tumor cells or micrometastases.
Pesce C; Balch C; Jacobs L
Breast Dis; 2010; 31(2):99-106. PubMed ID: 21368372
[TBL] [Abstract][Full Text] [Related]
18. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
Cserni G
Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
20. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
